Akari Therapeutics (AKTX) Enterprise Value Growth (3y) (2014 - 2025)
Akari Therapeutics (AKTX) Enterprise Value Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.49% |
| Jun 30, 2025 | 30.21% |
| Dec 31, 2024 | 34.27% |
| Jun 30, 2024 | -3.28% |
| Dec 31, 2023 | 35.08% |
| Jun 30, 2023 | 17.34% |
| Dec 31, 2022 | -32.22% |
| Jun 30, 2022 | -43.88% |
| Dec 31, 2021 | -16.19% |
| Jun 30, 2021 | 36.87% |
| Dec 31, 2020 | 20.63% |
| Jun 30, 2020 | 24.92% |
| Dec 31, 2019 | 49.35% |
| Jun 30, 2019 | 63.39% |
| Mar 31, 2019 | 53.58% |
| Dec 31, 2018 | 55.76% |
| Jun 30, 2018 | -321.36% |
| Dec 31, 2017 | -103.66% |
| Jun 30, 2017 | -38.41% |
| Dec 31, 2016 | -330.33% |